ORION PHARMA A/S: Financial statements 2017
CVR: 20601116
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ORION PHARMA A/S (CVR 20601116) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 327,737,984 and a net result of DKK 37,821,319 compared with DKK 56,727,015 the year before. That is a decrease of 12.3% compared with the year before. The profit margin was 11.5%. Equity in the 2017 report amounted to DKK 95,162,936. The solvency ratio was 72.3%. The company had 29 employees in the financial year.
- Revenue
- DKK 327,737,984
- Gross Profit
- DKK 73,018,412
- Profit/Loss
- DKK 37,821,319
- Equity
- DKK 95,162,936
- Total Assets
- DKK 131,550,542
- Employees
- 29
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 327.7 mio. | 73 mio. | 37.8 mio. | 95.2 mio. | 29 |
| 2016 | 373.7 mio. | 101 mio. | 56.7 mio. | 97.3 mio. | 29 |
| 2015 | 273 mio. | 85.3 mio. | 44.8 mio. | 66.6 mio. | 28 |
| 2014 | 166.9 mio. | 59.3 mio. | 24.7 mio. | 46.8 mio. | 31 |
| 2013 | 164.8 mio. | 64.9 mio. | 25.6 mio. | 39.1 mio. | 33 |
Official annual report
Keep an eye on ORION PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ORION PHARMA A/S has published its annual report for 2016. Revenue came to DKK 373,655,929, and the net result was DKK 56,727,015.
About ORION PHARMA A/S
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ERCOPHARM A/S. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 14 employees (2026). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.